New drugs for treatment of ventricular arrhythmias

J. J. Heger, E. N. Prystowsky, D. P. Zipes

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


This article has attempted to review selected clinical features of new antiarrhythmic agents for treatment of recurrent ventricular tachycardia and ventricular fibrillation. While it is apparent that the ideal antiarrhythmic agent does not exist, whether it be a new or old antiarrhythmic drug, effective and safe antiarrhythmic drug therapy can nevertheless be administered to many patients if the pharmacologic principles and properties described herein are carefully considered.

Original languageEnglish (US)
Pages (from-to)475-483
Number of pages9
JournalHeart and Lung: Journal of Acute and Critical Care
Issue number3
StatePublished - 1981

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'New drugs for treatment of ventricular arrhythmias'. Together they form a unique fingerprint.

Cite this